ArticleBMJ (Clinical research ed.)2018

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.

Devin Abrahami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.